会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 67. 发明授权
    • Oligonucleotides comprising a non-phosphate backbone linkage
    • 包含非磷酸骨架键的寡核苷酸
    • US07723512B2
    • 2010-05-25
    • US12496250
    • 2009-07-01
    • Muthiah ManoharanKallanthottathil G. Rajeev
    • Muthiah ManoharanKallanthottathil G. Rajeev
    • C07H19/00C07H19/22
    • C12N15/111C07H19/04C07H19/12C07H19/16C07H19/167C07H19/173C07H21/02C12N15/1136C12N15/1137C12N2310/14C12N2310/312C12N2320/51
    • One aspect of the present invention relates to a ribonucleoside substituted with a phosphonamidite group at the 3′-position. In certain embodiments, the phosphonamidite is an alkyl phosphonamidite. Another aspect of the present invention relates to a double-stranded oligonucleotide comprising at least one non-phosphate linkage. Representative non-phosphate linkages include phosphonate, hydroxylamine, hydroxylhydrazinyl, amide, and carbamate linkages. In certain embodiments, the non-phosphate linkage is a phosphonate linkage. In certain embodiments, a non-phosphate linkage occurs in only one strand. In certain embodiments, a non-phosphate linkage occurs in both strands. In certain embodiments, a ligand is bound to one of the oligonucleotide strands comprising the double-stranded oligonucleotide. In certain embodiments, a ligand is bound to both of the oligonucleotide strands comprising the double-stranded oligonucleotide. In certain embodiments, the oligonucleotide strands comprise at least one modified sugar moiety. Another aspect of the present invention relates to a single-stranded oligonucleotide comprising at least one non-phosphate linkage. Representative non-phosphate linkages include phosphonate, hydroxylamine, hydroxylhydrazinyl, amide, and carbamate linkages. In certain embodiments, the non-phosphate linkage is a phosphonate linkage. In certain embodiments, a ligand is bound to the oligonucleotide strand. In certain embodiments, the oligonucleotide comprises at least one modified sugar moiety.
    • 本发明的一个方面涉及在3'-位被亚磷酰胺基取代的核糖核苷。 在某些实施方案中,亚磷酰胺是烷基亚磷酰胺。 本发明的另一方面涉及包含至少一种非磷酸键的双链寡核苷酸。 代表性的非磷酸酯键包括膦酸酯,羟胺,羟基肼基,酰胺和氨基甲酸酯键。 在某些实施方案中,非磷酸酯键是膦酸酯键。 在某些实施方案中,非磷酸酯键仅出现在一条链中。 在某些实施方案中,在两条链中都发生非磷酸连接。 在某些实施方案中,配体与包含双链寡核苷酸的寡核苷酸链之一结合。 在某些实施方案中,配体与包含双链寡核苷酸的两条寡核苷酸链结合。 在某些实施方案中,寡核苷酸链包含至少一个修饰的糖部分。 本发明的另一方面涉及包含至少一种非磷酸键的单链寡核苷酸。 代表性的非磷酸酯键包括膦酸酯,羟胺,羟基肼基,酰胺和氨基甲酸酯键。 在某些实施方案中,非磷酸酯键是膦酸酯键。 在某些实施方案中,配体与寡核苷酸链结合。 在某些实施方案中,寡核苷酸包含至少一个修饰的糖部分。